Target intelligence / Profile preview

Microbial flora of eyelid and eyelash surface

Molecular classification
Other
01

Overview

The microbial flora on eyelid/lash surface refers to the community of microorganisms (mainly bacteria) found on the surface of the eyelid and eyelashes, not a single molecule, gene, or protein. As such, it is not a canonical drug target like a receptor, enzyme, or transporter. The microbial flora of the eyelid and eyelash surface refers to the diverse communities of bacteria and other microorganisms colonizing the eyelid margin and lashes. The most commonly reported bacterial genera include Staphylococcus, Corynebacterium, Propionibacterium, as well as Lactobacillus, Ralstonia, Bacteroides, Acinetobacter, among others. These communities help maintain ocular surface health by competing with pathogenic organisms and modulating local immune responses. Disruptions to these communities (dysbiosis) are associated with eye conditions such as blepharitis, meibomian gland dysfunction, and ocular infections. Therapeutic interventions typically address the microbiome as a whole (e.g., with antibiotics or antiseptics) rather than targeting a specific molecular entity. Changes in the relative abundance of specific bacteria (notably Staphylococcus and Corynebacterium) are considered important biomarkers for health and disease of the eyelid margins. Selecting interventions requires consideration of the risk of dysbiosis, antibiotic resistance, and negative shifts in the microbial ecosystem.

Other names
Eyelid/lash surface microbiotaOcular surface microbiomeOcular surface flora
02

Mechanism of action

Inhibition or killing of bacterial species Modulation of microbial community composition Reduction of microbial load to prevent or treat inflammation/infection

03

Biological functions

Maintenance of ocular surface homeostasisCompetition with pathogenic organismsModulation of local immune responses
04

Disease associations

Ocular infectionBlepharitisMeibomian gland dysfunctionDry eye disease
05

Safety considerations

Disruption of commensal flora may lead to colonization by opportunistic pathogensEmergence of antibiotic resistancePrecipitation of dysbiosis or loss of protective species
06

Interacting drugs

Antibiotics (topical, e.g., azithromycin, tobramycin)

2 more in the full profile.

07

Biomarkers

Changes in abundance of key bacterial genera (e.g., Staphylococcus, Corynebacterium, Propionibacterium, Lactobacillus, Ralstonia)Shifts in microbiota diversity

Beyond the preview

Go deeper on Microbial flora of eyelid and eyelash surface.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Microbial flora of eyelid and eyelash surface.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call